Oncolytics Biotech
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 c...
Oncolytics Biotech Logo
About Oncolytics Biotech
Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.
Address
322 11th Avenue SW, Suite 804
Calgary, T2R 0C5
Canada
Year founded
1998
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
